論文・総説 - 吉村　亮一

21. Noji R, Tohyama K, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Michi Y, Tasaki A, Ohno K, Ariizumi Y, Onishi I, Suenaga M, Mori T, Okamoto R, Yoshimura R, Miura M, Asakage T, Miyake S, Ikeda S, Harada H, Kano Y. Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer CANCERS. 2022.07; 14 (14): ( PubMed, DOI )

22. Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AY, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2022.04; 52 (8): 851-860. ( DOI )

23. Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S. Safety and response after peptide receptor radionuclide therapy with 177Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial Journal of Hepato-Biliary-Pancreatic Sciences. 2022.04; 29 (4): 487-499. ( 医中誌 )

24. Usami A, Yokoyama K, Tsuchiya J, Umezawa Y, Toda K, Tateishi U, Yoshimura R. A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [F-18]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose DIAGNOSTICS. 2022.02; 12 (2): ( PubMed, DOI )

25. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response CANCERS. 2022.02; 14 (3): ( PubMed, DOI )

26. Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma ORAL ONCOLOGY. 2022.01; 124 105666. ( PubMed, DOI )

27. Yoshimura Ryo-ichi, Toda Kazuma, Watanabe Hiroshi, Kaida Atsushi, Harada Hiroyuki, Asakage Takahiro, Miura Masahiko. Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer ANTICANCER RESEARCH. 2021.12; 41 (12): 6259-6266. ( DOI )

28. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2021.12; ( PubMed, DOI )

29. Sasamura K, Soyano T, Kozuka T, Yuasa T, Yamamoto S, Yonese J, Oguchi M, Yoshimura R, Yoshioka Y. Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study. Japanese journal of clinical oncology. 2021.10; ( PubMed, DOI )

30. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

31. Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy IJU Case Reports. 2021.07; 4 (4): 228-230. ( 医中誌 )

32. Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Tateishi Ukihide, Fujii Yasuhisa. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer EUROPEAN RADIOLOGY. 2021.06; ( PubMed, DOI )

33. Kabasawa Yuji, Ito Kanade, Tokura Shiori, Takazawa Itsuki, Kimura Rio, Nakanishi Tohko, Akiyama Kikue, Onuma Yuki, Adachi Toshiko, Komiya Ruri, Harada Hiroyuki, Nojima Hitomi, Miura Masahiko, Yoshimura Ryoichi. 頭頸部がんへの放射線化学療法時に発症する口腔粘膜炎に対して、エピシル口腔用液が及ぼす効果に関するの臨床研究(Clinical Investigation of Episil Oral Solution for Oral Mucositis during Radiochemical Treatment for Head and Neck Cancer) 日本口腔ケア学会雑誌. 2021.04; 15 (3): 264. ( 医中誌 )

34. Furusawa A, Takekuma M, Mori K, Usami T, Kondo E, Nishio S, Nishino K, Miyamoto Y, Yoshimura R, Watanabe M, Mikami M, Enomoto T. A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2021.03; ( PubMed, DOI )

35. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? INTERNATIONAL JOURNAL OF UROLOGY. 2021.02; 28 (2): 241-242. ( PubMed, DOI )

36. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International Journal of Urology. 2021.02; 28 (2): 241-242. ( 医中誌 )

37. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed, DOI )

38. Saito Kazutaka, Matsuoka Yoh, Toda Kazuma, Yoshida Soichiro, Yokoyama Minato, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer BRACHYTHERAPY. 2021; 20 (4): 842-848. ( PubMed, DOI )

39. Towithelertkul C, Chugh A, Hattori M, Yoshimura R, Sumita YI. A custom-made brachytherapy applicator for recurrent endometrial and vaginal cancer: A dental technique for prosthesis fabrication. The Journal of prosthetic dentistry. 2020.11; ( PubMed, DOI )

40. Hirai H, Ohsako T, Kugimoto T, Tomioka H, Michi Y, Kayamori K, Yoda T, Miura M, Yoshimura R, Harada H. Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma. Oral oncology. 2020.08; 107 104708. ( PubMed, DOI )